Considering that we observed significant Sfrp1 dependent changes in the gluconeogenic transcripts in the liver, and non-alcoholic fatty liver disease is tightly associated with obesity and hyperglycemia [31], we chose to examine the effects of a HFD in the livers of these mice. The gene discussed is SFRP1; the disease is metabolic dysfunction-associated steatotic liver disease.